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ABSTRACT 
 
Acinetobacter baumannii which is gram-negative rod and infecting hospitalized patient often develops multiple drug 
resistance patterns and causes serious problem in treatment. The aim of this study is to determine the relationship 
between this serious problem in treatment and Presence of some β-lactamase genes in the A. baumannii. 100 isolates 
of Acinetobacter collected from hospitalized patients in Tehran. First their resistance to different antibiotics were 
determined using disk agar diffusion test then the MICs of all resistant isolates determined by Etest .In the second 
stage we screened all resistance isolates for β-lactamase gene existence by double-disk synergy test and finally 
prevalence of β-lactamase encoding genes such as IMP-1,SIM-1,OXA-23,OXA-24 and OXA-58 were determined 
by PCR. According those tests the most efficient treatment was achieved by Colistin, Gentamicin, and Imipenem. 
Disk synergy test with 0.1M EDTA determined 23 % of isolates as metalo β-lactamase producers. Prevalence of β- 
lactamase encoding genes was: 4%, 0%, 38%, 32%, and 1% respectively. According to this study efficient treatment 
will be influenced by OXA β-lactamase more than the other genes which have been studied. This is the first report 
of SIM type among MBL-producing A. baumannii in Iran. 
KEY WORDS: Acinetobacter baumannii, β-lactamase, efficient treatment, PCR, Molecular typing.  
 
INTRODUCTION 
 
Acinetobacter baumannii is a gram-negative rod that causes an extensive range of serious infections such 
aspneumonia, sepsis and meningitis that frequently occurs in the strictly ill patients of ICU [1, 2] .There is a 
universal incessant rise in bacteremia incidence and mortality rate, mainly attributed to the increased usage of 
invasive devices [3].Risk factors are including antibiotic exposure, length of stay in ICU and basic disease. [2, 4]. 
Extensive use of empirical antibiotic chemotherapy has contributed to the appearance and increasing the 
number of A. baumannii strains resistant to a wide range of antibiotics, including broad-spectrum beta-lactams [5]. 
Recent reports also showed that the spread of the β-lactamase-mediated carbapenem resistance is the most common 
mechanism found in A. baumannii isolates carried out by the class B Metallo-β- lactamases (MBL) such as (IMP-1 
and SIM-1 enzymes) or carbapenem-hydrolyzing class D β -lactamases (CHDLs) such as (OXA-23, 24, 51 and 58 -
related families) [6, 7].MBLs and CHDLs have been identified worldwide from carbapenem-resistant A. 
baumanniistrains.MBLs are powerful carbapenemases, and can hydrolyze a wide variety of β -lactams, including 
Penicillins, Cephalosporins,andCarbapenems [6, 7]. Infections are often difficult to treat since Carbapenems are now 
almost always the drug of choice for the treatment of Acinetobacter infections [8] and in some cases are associated 
with high morbidity and mortality rates [9].There are clear geographic differences in the prevalence of these 
mechanisms of β-lactamase resistance. [10, 11, 12].For this reason there have been extensive surveillance and 
research efforts worldwide focusing on the antibiotic susceptibilities [13, 14] and mechanisms of resistance [13, 15] 
of A. baumannii clinical isolates. 
 In Iran, our data on prevalence of β –lactamases gene and Correlation with antibiotic susceptibility pattern is very 
limited. In fact all the aim of this study is to acquire awareness about susceptibility patterns and Choice the best 
empirical therapy and more effective treatment in Tehran and probably other Persian Gulf countries׳s hospitalized 
patients. 
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METHODS 
 
Features of Study and Specimens. This is a cross-sectional study performed in 8 different hospitals from August 
2009 to March 2010. The protocol of this study was accepted by the Technical Committee of the medical 
microbiology department of Shahed University. A total of 100 non-duplicate isolates of A.baumannii were collected 
from different clinical specimens of patients, who were hospitalized for ≥48 hours at different wards. Isolates were 
confirmed as A. baumannii by conventional biochemical testing and existence of gene encoding of 
OXA51Amplicons. The isolated were then stored at –80°C in nutrient broth containing 50% glycerol v/v for further 
investigation. 
 
Antimicrobial susceptibility test.Antimicrobial susceptibility was determined by disk diffusion method as 
recommended by the Clinical and Laboratory Standards Institute (CLSI) [16]. Minimum inhibitory concentrations 
(MICs) were determined by E-test (AB BIODISK, SOLNA, Sweden) according to the manufacturer's specifications. 
In brief for the E-test, 150-mm-diameter Muller-Hinton agar plates were inoculated with swabs saturated with 
suspensions of the isolates at 0.5 McFarland standards. The antimicrobial concentration ranges were: Piperacillin; 
0.016- 256 µg/ml,  Piperacillin/tazobactam; 0.016-256µg/ml, Ampicillin/sulbactam; 0.016- 256 µg/ml, 
Ciprofloxacin; 0.002 - 32 µg/ml, Ceftriaxone; 0.002-32 µg/ml, Cefotaxime 0.002-32 µg/ml, Ceftazidime; 0.016-
256µg/ml,Cefepime; 0.016-256µg/ml, Colistin; 0.064-1024µg/ml, Tetracycline; 0.016-256 µg/ml, Imipenem; 0.016-
256µg/ml, Amikacin; 0.016-256µg/ml and, Gentamicin; 0.016- 256 µg/ml. The results were read after 18 to 24 
hours of incubation at 35°C. Quality control was performed using Escherichia coli ATCC 25922 and Pseudomonas 
aeruginosa ATCC 27853 strains. 
 
Metalloβ -lactamase (MBL) producer screening. MBL-producing strains were screened with double-disk synergy 
tests (DDST) by placing 20 mm apart one Imipenem (10 µg) disk as substrate and another with 10µl 0.1 M EDTA 
(SIGMAChemical, ST. LOUIS, MO) as β-lactamase inhibitors. The zone around the Imipenem disk is extended on 
the side near the EDTA disk for a MBL producer [17]. 
 
DNA Extraction. DNA was extracted from the strains by boiling one to three colonies in 100 μl of sterile ultra-pure 
water for 10 min followed by centrifugation for 1 min at 14,000 rpm [18]. 
 
β-lactamase gene detectionby PCR.Primers used for amplification of blaOXA-51, blaOXA-23, blaOXA-24, 
blaOXA-58, IMP-1 and SIM-1 are given in Table 1. 
 
Table 1.Oligonucleotides and other data used for detection of the β-lactamase genes 
Target gene Oligonucle
otide 
Sequence Annealing 
Temperature 
(°C ) &Time (Sec) 
Size of 
Amplicons 
(bp) 
Reference 
blaOXA-51 OXA-51 F 5´-TAA TGC TTT GAT CGG CCT TG-3´ 52,45 353 (18) 
blaOXA-51 OXA-51 R 5´-TGG ATT GCA CTT CAT CTT GG-3'    
blaOXA-23 OXA-23 F             5´-GAT CGG ATT GGA GAA CCA GA-3' 52,45 501 (18) 
blaOXA-23 OXA-23 R 5´-ATT TCT GAC CGC ATT TCC AT-3´    
blaOXA-24 OXA-24 F 5´-GGT TAG TTG GCC CCC TTA AA-3´ 52,45 246 (18) 
blaOXA-24 OXA-24 R            5´-AGT TGA GCG AAA AGG GGA TT-3´    
blaOXA-58 OXA-58 F                5´-AAG TAT TGG GGC TTG TGC TG-3´ 52,45 599 (18) 
blaOXA-58 OXA-58 R 5´-CCC CTC TGC GCT CTA CAT AC-3´    
blaSIM-1 SIM-1 F 5´-TAC AAG GGA TTC GGC ATC G-3´ 43,30 570 (19) 
blaSIM-1 SIM-1R 5´-TAA TGG CCT GTT CCC ATG TG-3´    
blaIMP-1 IMP-1F 5´-AAC CAG TTT TGC CTT ACC AT-3´ 43,30 188 (19) 
blaIMP-1 IMP-1R 5´-CTA CCG CAG CAG AGT CTT TG-3´    
 
PCR was performed with 5μL of heat-extracted DNA template, 1 μl of each primer, 3 μldNTP, 1.25μL Mgcl2 
25mM and 3μL ofTaq DNA polymerase in a total volume of 30 μl. A Master cycler instrument (TECHNETouch 
gene Gradient Thermal Cyclers - Krackeler Scientific Inc.UK.) was used with the following reaction conditions: 
94°C for 2min 35 cycles , 94°C for 1 min, 43-52°C for 30-45 Sec, and 72°C for 90 sec, and finally, 72°C for 7 min. 
PCR products were separated by electrophoresis on a 1% agarose gel and were detected by ethidium bromide 
staining  and comparison against a 100 bp DNA ladder as a size marker under the visualization of UV light. 
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Statistical analysis. Collected data analyzed in SPSS V 16 software using descriptive statistical methods such as 
table, graph and mean+/- SD.  Universal analysis was conducted using student's t test, ANOVAs for quantitative and 
chi-square for categorical variables.  
RESULTS 
 
A total of 100 samples were obtained. Patients' medical records were referred to extract clinical information 
such as age  (n=2;0-20 years, n=38;21-40 years, n=33;41-60 years,n=24;61-80 years,n= 3;81-100 years ) , sex (men; 
n=50,women;n=50) and hospital location. The organisms were isolated from blood (n=8), urine (n=7), cerebral 
spinal fluid (CSF) (n=3), Sputum (n=8), pleura fluid (n=10), Wound (n=34), Catheter (n=7)Broncho alveolar lavage 
(BAL) (n=22), Synovial fluid (n=1). The majority of isolates were obtained from patients in intensive care units 
(n=54), Burn (n=18), Urology (n=4), Orthopedic (n=2) and Internal medicine (n=22) wards. The most important site 
for obtained of A. baumanniiwas Wound and the most frequent ward of hospital was intensive care unit(54%) 
followed by Internal (22%), Burn (18%), Urologic (4%), Orthopedic Wards. (2%).Distribution of antimicrobial 
resistance among A.  baumannii isolates at 8 different hospitals of Tehran is shown in Table 2. 
 
Table 2. Distribution of antimicrobial resistance among A.baumannii isolates at 8 differenthospitals of Tehran 
Hospital 
 
Antibiotic 
H1 
 
n=26 
H2  
 
n=17 
H3 
 
n=14 
H4  
 
n=10 
H5  
 
n=9 
H6  
 
n=9 
H7 
 
n=8 
H8 
 
n=7 
p-value 
Piperacillin 26(100%) 17(100%) 14(100%) 10(100%) 9(100%) 9(100%) 8(100%) 7(100%) 0.0018 
Piperacillin/ 
Tazobactam 
 
24(92.3%) 
 
 
15(88.2%) 
 
 
12(85.7%) 
 
 
7(70%) 
 
 
9(100%) 
 
 
9(100%) 
 
 
6(75%) 
 
 
7(100%) 
 
0.002 
Ampicillin-
sulbactam            
 
15(57.6%) 
 
14(82.3%) 
 
7(50%) 
 
8(80%) 
 
5(55.5%) 
 
3(33.3%)   
 
5(62.5%) 
 
5(71.4%) 
0.013 
Ciprofloxacin 26(100%) 17(100%) 13(92.8%) 9(90%) 7(77.7%) 8(88.8%) 6(75%) 7(100%) 0.0002 
Ceftriaxone  26(100%) 17(100%) 14(100%) 10(100%) 7(77.7%) 8(88.8%) 7(87.5%) 7(100%) 0.0004 
Cefotaxime 26(100%) 17(100%) 14(100%) 10(100%) 8(88.8%) 8(88.8%) 8(100%) 7(100%) 0.0009 
Ceftazidime 26(100%) 
 
16(94.1%) 
 
13(92.8%) 
 
9(90%) 
 
8(88.8%) 
 
8(88.8%) 
 
6(75%) 
 
7(100%) 
 
0.0003 
Cefepime 25(96.1%) 17(100%) 14(100%) 10(100%) 9(100%) 9(100%) 8(100%) 6(85.7%) 0.0024 
Colistin 5(19.2%) 0(0%) 0(0%) 1(10%) 1(11.1%) 0(0%) 2(25%) 0(0%) 0.18 
Tetracycline 20(76.9%) 
 
12(70.5%) 
 
 7(50%) 
 
7(70%) 
 
5(55.5%) 
 
4(44.4%) 
 
4(57.1%) 
 
7(100%) 
 
0.0009 
Imipenem 11(42.3%) 9(52.9%) 10(71.4%) 6(60%) 3(33.3%) 3(33.3%) 5(62.5%) 6(85.7%) 0.19 
Amikacin 13 (50%) 13(76.4%) 
 
8(57.14%) 
 
7(70%) 
 
4(44.4%) 
 
5(55.5%) 
 
7(87.5%) 
 
5(71.4%) 
 
0.13 
Gentamicin 8(30.7%) 10(58.8%)  6(42.8%) 5(50%) 3(33.3%) 3(33.3%) 5(62.5%) 5(71.4%) 0.42 
H1;Motahhari,H2;Imam Hossain, H3;Millad,H4;Mustafa,H5;Imam Khomeini,H6;Loghman,H7;Labbafinejad,H8;Khatamanbia.  
 
Distribution of antimicrobial resistance among A. baumannii isolates according to different sample origins is shown 
in Table 3. 
 
Table 3.Distribution of antimicrobial resistance among A. baumannii isolates according todifferent sample origins 
S.Origin 
 
Antibiotic 
 
Wound 
n=34 
 
Synovialfluid 
n=1 
 
Sputum 
n=8 
 
Blood 
n=8 
BAL 
n=22 
Pleura 
fluid 
n=10 
Catheter 
n=7 
Urine 
n=7 
CSF 
n=3 
p-value 
Piperacillin 34(100%) 1(100%) 8(100%) 8(100%) 22(100%) 10(100%) 7(100%) 7(100%) 3(100%) 0.001 
Piperacillin/ 
Tazobactam 
 
30(88.2%) 
 
0(0%) 
 
8(100%) 
 
5(62.5%) 
 
22(100%) 
 
10(100%) 
 
7(100%) 
 
5(71.4%) 
 
2(66.6%) 
0.002 
Ampicillin-
sulbactam 
20(58.8%) 1(100%) 6(75%) 5(62.5%) 17(77.2%) 6(60%) 1(14.2%) 5(71.4%) 1(33.3%) 0.003 
Ciprofloxacin 34(100%) 1(100%) 7(87.5%) 7(87.5%) 21(95.4%) 9(90%) 6(85.7%) 5(71.4%) 3(100%) 0.001 
Ceftriaxone 33(97.0) 1(100%) 8(100%) 8(100%) 22(100%) 9(90%) 7(100%) 5(71.4%) 3(100%) 0.001 
Cefotaxime 34(100%) 1(100%) 8(100%) 8(100%) 22(100%) 10(100%) 7(100%) 5(71.4%) 3(100%) 0.001 
Ceftazidime 31(91.1%) 1(100%) 8(100%) 6(75%) 22(100%) 10(100%) 6(85.7%) 6(85.7%) 3(100%) 0.004 
Cefepime 33(97%) 1(100%) 8(100%) 8(100%) 22(100%) 10(100%) 7(100%) 6(85.7%) 3(100%) 0.001 
Colistin 3(8.8%) 0(0%) 3(37.5%) 0(0%) 2(9%) 0(0%) 0(0%) 1(14.2%) 0(0%) 0.74 
Tetracycline 28(82.3%) 0(0%) 6(75%) 6(75%) 14(63.6%) 4(40%) 4(57.1%) 2(28.5%) 2(66.6%) 0.001 
Imipenem 15(44.1%) 1(100%) 4(50%) 5(62.5%) 15(68.1%) 5(50%) 3(42.8%) 4(57.1%) 1(33.3%) 0.0024 
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From among all antibiotics Colistin, Imipenem, Amikacin and Gentamicin have not statistically significant 
difference in various hospitals but other antibiotics have significant difference (Table 2).From among all antibiotics 
Colistin has not statistically significant difference in Various sample origins but other antibiotics have significant 
difference (Table 3). 
The most effective antimicrobial agents against A. baumannii isolates among the antimicrobials tested were 
Colistin, Gentamicin and then Imipenem. This study indicated high level resistance in Acinetobacter baumannii 
strains isolate (Figures1-2). 
Of 100 isolates of A. baumannii, 23% were found to be producing MBL by DDST.β-lactamase gene of isolates 
gave PCR products of various sizes ranging from 188 bp to 599 bp (Table 1) and(Figures3-4).Based on this 
evaluation, PCR detecting β-lactamase gene showed as follow: OXA-51 n=100(100%), OXA-58 n=1(1%), OXA-23 
n=38(38%), OXA-24 n=32 (32%), IMP-1 n=4(4%) and finally SIM-1 n=0(0%). All isolates harbored OXA-
51,Whereasthere was not any Ampicillin-sulbactam resistant isolates harboring OXA-58, However, Ceftriaxone and 
Cefotaxime resistant isolates were the most common OXA-23 harboring isolates (30.2%,29.5%) respectively. 
Cefotaxime and Ceftazidime resistant isolates were the most common OXA-24 harboring isolates (32.6%, 31.1%) 
respectively. Imipenem resistant isolates were the most common IMP-1 harboring isolates (7.5%). The relationship 
between antibiotic resistance and the existence of different β-lactamase gene is shown in Table 4. The association 
between drug resistance to all antibiotics and the presence of β-lactamase gene had statistically significant difference 
(Table 4). 
 
Table 4.The relationship between antibiotic resistance and the existence of different β-lactamase gene in isolates of 
A. baumannii 
p-value   presence  Gene 
 
  Number of 
Resistant 
isolate 
Antibiotic   
 SIM-1 
n (%) 
IMP-1 
n (%) 
OXA-24 
n (%) 
OXA-23 
n (%) 
OXA-58 
n (%) 
OXA-51 
n (%) 
0.001  0   (0) 4(4) 29(29) 25(25) 1(1) 100(100) 100 Piperacillin 
0.001  0   (0) 2(2.2) 23(25.8) 16(17.9) 1(1.1) 89(100) 89 Piperacillin/ 
Tazobactam 
0.002  0   (0) 2(3.2) 14(22.5) 16(25.8) 0(0) 62(100) 62 Ampicillin/ 
Sulbactam 
0.0012  0   (0) 3(3.1) 25(26) 29(30.2) 1(1.0) 96(100) 96 Ceftriaxone  
0.001  0   (0) 3(3.0) 32(32.6) 29(29.5) 1(1.0) 98(100) 98 Cefotaxime 
0.003  0   (0) 3(3.2) 29(31.1) 25(26.8) 1(1.0) 93(100) 93 Ceftazidime 
0.001  0   (0) 4(4.0) 19(19.3) 19(19.3) 1(1.0) 98(100) 98 Cefepime 
0.005  0   (0) 4(7.5) 10(18.8) 11(20.7) 1(1.88) 53(100) 53 Imipenem 
 
 
 
Fig. 1.A. baumannii, clinical isolates Antibiogram; disk diffusion method. 
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Fig. 2.Minimum inhibitory concentrations by E-test 
(AB BIODISK, SOLNA, Sweden). 
 
 
 
Fig. 3. PCR of OXA-51 among clinical 
A. baumannii isolates Lane 1 (DNA Ladder 100bp). Lane 2(Positive control) Lane 3(Negative control) 
Lanes 4-11 (clinical positive isolates). 
 
 
 
Fig. 4.PCR of OXA-24among clinical A. baumanniiisolates.Lane 1 (DNALadder 100 bp). Lane 2 (Positive control),Lanes 3-6 
(clinical positive isolates). 
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DISCUSSION 
 
Unfortunately due the lack of updated and efficient information about antibiotic susceptibility pattern and high 
Capacity of the A.baumannii, this Opportunistic organisms gain the powerful resistance to the most of drugs 
Treatment. In this study we attempt to gain effective and sufficient information about antibiotic resistance pattern 
and presence of some β-lactamase genes. In fact the aim of this study is to increase the augury power of failing or 
successes of treatment. 
In the current study, most samples were isolated from the wound (34%) and the other important source was 
bronco alveolar lavage (BAL=22%).In the studies which have been reported from Iran and other countries the Most 
of samples were isolated from the Wounds [18, 20, 21], tracheal tube aspiration [22]. and respiratory system [17]. 
This Similarity between the origins of samples, Is due to the fact that the injured tissue because of burning or using 
invasive device such as ventilator is appropriate location for growing microbe. 
Our study results are in agreement with reports from the other study which showed high prevalence rate of 
A.baumannii isolation in ICU [20, 2]. This high incidence may be due to the use of aggressive therapeutic agent in 
these wards. 
Now the three most effective antibiotics against Acinetobacter were found to be Colistin, Gentamicin and 
Imipenem. Our study results are in agreement with the other report from Tehran that has shown low resistance to the 
Colistin and Imipenem.[23]. In past years low resistance rates of A. baumannii to Imipenem (about 3%) were 
reported from Saudi Arabia and Japan ,4.5% from Tehran Hospitals and 9.6% from Turkey [22] but now this 
Resistance rate is 53% in this study, 43.7% in Turkey and 43% in Spain [22].On the other hand our study results are 
in agreement with the reports from the other countries that have shown high resistance to the most of the prescribed 
antibiotics such as CTX, CAZ, CIP, SXT (90–100%) in Germany [24] and Cephalosporins in Europe (15% to 97%) 
[25].Regional variation in resistance of A. baumannii to Imipenem and other antibiotics is related to the previous 
pattern of antimicrobial use and risk factors such as duration of hospital and ICU stay, usage of the endotracheal 
tube, venous catheter and urinary catheter.  
In this study, the class D β -lactamases were detected more frequently than MBLs thus blaOXA-51 harbored in 
all Isolates and blaOXA-58, blaOXA-23 and blaOXA-24 genes were detected in1, 38 and 32 isolates respectively, 
Whereas blaIMP-1 and blaSIM-1 were detected only in 4 and 0 isolates respectively. Our results regarding blaOXA-
51 were in agreement with other studies [26],.In one study in Colombia Sixty five of the 66 isolates were positive 
for blaOXA-23 genes and all 66 were positive for blaOXA-51 genes, Whereas all  of them were negative for 
blaOXA-58 and blaOXA-24 genes [27].In another published study all of 1018 isolates were positive by PCR for bla 
OXA-23- and blaOXA-51 genes in China Whereas no IMP, SIM-1, OXA-58 or OXA-24 genes were detected. [28]. 
In one study in Korea only 7 strains from 31 isolate harbored blaOXA-23, 15 isolates had blaIMP whereas there was 
not any OXA type β -lactamase gene, including blaOXA-24 , and blaOXA-58 [6].In the recent study in Iran 19 
isolates from 100 isolates carried the blaIMP gene [16]. These various results may suggest that very mechanisms or 
genes have contributed to the Carbapenem resistance in these isolates (e.g., reduced affinity of penicillin-binding 
proteins and decreased permeability of the outer membrane). 
Our results also indicate that there is a significant statistical difference between resistance to some antibiotics, 
hospitals, different wards of hospitals and beta lactamase genes. At the present time, the most effective drug for 
treatment of patients is usage of Colistin, Gentamicin and Imipenem. 
Considering the results of this research, it seems that we can predict the drug resistance or lack of it, but it is 
necessary to gain updated and complete information regarding genes and resistance mechanisms with continual 
molecular monitoring of resistance pattern which finding of this research, are a small effort to achieve the above 
mentioned goal. 
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